✦ LIBER ✦

Structure-Based Design of a Novel, Potent, and Selective Inhibitor for MMP-13 Utilizing NMR Spectroscopy and Computer-Aided Molecular Design

✍ Scribed by Chen, James M.; Nelson, Frances C.; Levin, Jeremy I.; Mobilio, Dominick; Moy, Franklin J.; Nilakantan, Ramaswamy; Zask, Arie; Powers, Robert

Book ID: 127021801
Publisher: American Chemical Society
Year: 2000
Tongue: English
Weight: 588 KB
Volume: 122
Category: Article
ISSN: 0002-7863
DOI: 10.1021/ja001547g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure-Based Design of Potent and Sel

Structure-Based Design of Potent and Selective Inhibitors of Collagenase-3 (MMP-13).

✍ Soong-Hoon Kim; Andrew T. Pudzianowski; Kenneth J. Leavitt; Joseph Barbosa; Patr 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

BCX-1812 (RWJ-270201): Discovery of a No

BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

✍ Babu, Y. Sudhakar; Chand, Pooran; Bantia, Shanta; Kotian, Pravin; Dehghani, Ali; 📂 Article 📅 2000 🏛 American Chemical Society 🌐 English ⚖ 363 KB

Structure-Based Design of a Potent and S

Structure-Based Design of a Potent and Selective Small Peptide Inhibitor of Mycobacterium tuberculosis 6-Hydroxymethyl-7, 8-Dihydropteroate Synthase: A Computer Modelling Approach

✍ Gita Subba Rao; Manoj Kumar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 698 KB

Structure-Based Drug Design of RN486, a

Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis

✍ Lou, Yan; Han, Xiaochun; Kuglstatter, Andreas; Kondru, Rama K.; Sweeney, Zachary 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 426 KB

ChemInform Abstract: BCX-1812 (RWJ-27020

ChemInform Abstract: BCX-1812 (RWJ-270201) (I): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor Through Structure-Based Drug Design.

✍ Y. Sudhakar Babu; et al. et al. 📂 Article 📅 2001 🏛 John Wiley and Sons ⚖ 27 KB 👁 1 views

PRO_SELECT: Combining Structure-Based Dr

PRO_SELECT: Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors

✍ Liebeschuetz, John W.; Jones, Stuart D.; Morgan, Phillip J.; Murray, Chris W.; R 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 318 KB